
zzso of the zzso zzso zzso by zzso zzso has been documented in a number of human zzso including gastrointestinal zzso tumor zzso zzso acute zzso leukemia zzso and zzso In addition, zzso or zzso zzso of this zzso has been zzso in numerous other zzso including zzso lung cancer and zzso zzso In this review, we discuss the rationale for and development of zzso zzso zzso zzso for the treatment of human zzso 

Studies were identified through a zzso search, review of zzso of relevant articles, and review of abstracts from national zzso 

Four zzso zzso zzso that have activity against zzso are currently being used in clinical trials, and one, zzso has recently been approved by the United States Food and Drug Administration for treating patients with chronic zzso zzso The role of zzso zzso in treating zzso zzso is zzso 

zzso therapy to inhibit the zzso activity of zzso is a rational approach to the treatment of zzso zzso Two key factors are the potency of a given inhibitor and the relative contribution of zzso zzso to the growth of the zzso Given our current understanding of zzso activity in human zzso the best candidate diseases for treatment with zzso zzso are zzso zzso zzso and possibly some cases of zzso Additionally, zzso zzso may play an zzso role in diseases such as zzso lung cancer, in which zzso zzso is secondary to zzso binding rather than an acquired zzso 

